Este artículo solo puede leerse en
pdf
Bibliografía
[1.]
D.L. Bhatt, E.J. Topol.
Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
JAMA, (2000), 284 pp. 1549-1558
[2.]
M.L. Simoons, GUSTO IV-ACS Investigators.
Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial.
Lancet, (2001), 357 pp. 1915-1924
[3.]
E. Boersma, R.A. Harrington, D.J. Moliterno, H. White, P. Théroux, F. Van de Werf, et al.
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.
Lancet, (2002), 359 pp. 189-198
Copyright ©
2011. Sociedad Española de Cardiología